164 related articles for article (PubMed ID: 11369668)
1. Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia.
Mesa RA; Li CY; Schroeder G; Tefferi A
Blood; 2001 Jun; 97(11):3665-7. PubMed ID: 11369668
[TBL] [Abstract][Full Text] [Related]
2. Comparison of peripheral blood interphase cytogenetics with bone marrow karyotype analysis in myelofibrosis with myeloid metaplasia.
Tefferi A; Meyer RG; Wyatt WA; Dewald GW
Br J Haematol; 2001 Nov; 115(2):316-9. PubMed ID: 11703327
[TBL] [Abstract][Full Text] [Related]
3. Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients.
Visani G; Finelli C; Castelli U; Petti MC; Ricci P; Vianelli N; Gianni L; Zuffa E; Aloe Spiriti MA; Latagliata R
Br J Haematol; 1990 May; 75(1):4-9. PubMed ID: 2375922
[TBL] [Abstract][Full Text] [Related]
4. An electron microscopic study of spleen in myelofibrosis with myeloid metaplasia.
Tavassoli M; Weiss L
Blood; 1973 Aug; 42(2):267-79. PubMed ID: 4793115
[No Abstract] [Full Text] [Related]
5. Blood and spleen haematopoiesis in patients with myelofibrosis.
Douay L; Laporte JP; Lefrancois G; Najman A; Dupuy-Montbrun MC; Lopez M; Giarratana MC; Gorin NC
Leuk Res; 1987; 11(8):725-30. PubMed ID: 3626614
[TBL] [Abstract][Full Text] [Related]
6. Increased granulocytic, erythrocytic, and megakaryocytic progenitors in myelofibrosis with myeloid metaplasia.
Chikkappa G; Carsten AL; Chanana AD; Chandra P; Cronkite EP
Am J Hematol; 1978; 4(2):121-31. PubMed ID: 677118
[TBL] [Abstract][Full Text] [Related]
7. Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition.
Prakash S; Hoffman R; Barouk S; Wang YL; Knowles DM; Orazi A
Mod Pathol; 2012 Jun; 25(6):815-27. PubMed ID: 22388763
[TBL] [Abstract][Full Text] [Related]
8. [Splenic extramedullary hematopoiesis in myelofibrosis. Pathogenetic considerations apropos of a personally studied case].
Piaserico PL; Piaserico GP
Minerva Med; 1983 Oct; 74(39):2313-8. PubMed ID: 6657100
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia.
Elliot MA; Yoon SY; Kao P; Li CY; Tefferi A
Eur J Haematol; 2002 Mar; 68(3):175-9. PubMed ID: 12068799
[TBL] [Abstract][Full Text] [Related]
10. Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia.
Barosi G; Rosti V; Massa M; Viarengo GL; Pecci A; Necchi V; Ramaioli I; Campanelli R; Marchetti M; Bazzan M; Magrini U
Br J Haematol; 2004 Mar; 124(5):618-25. PubMed ID: 14871248
[TBL] [Abstract][Full Text] [Related]
11. Palliative splenectomy in myelofibrosis with myeloid metaplasia.
Mesa RA; Tefferi A
Leuk Lymphoma; 2001; 42(5):901-11. PubMed ID: 11697645
[TBL] [Abstract][Full Text] [Related]
12. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
Mesa RA; Elliott MA; Tefferi A
Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
[TBL] [Abstract][Full Text] [Related]
13. Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly.
Wolf BC; Neiman RS
Blood; 1985 Apr; 65(4):803-9. PubMed ID: 3978228
[TBL] [Abstract][Full Text] [Related]
14. Increased erythrocytic and neutrophilic progenitors in myelofibrosis with myeloid metaplasia.
Ohl S; Carsten AL; Chanana AD; Chikkappa G; Cronkite EP
Eur J Cancer (1965); 1976 Feb; 12(2):131-5. PubMed ID: 1063073
[No Abstract] [Full Text] [Related]
15. C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients.
Wang X; Cho SY; Hu CS; Chen D; Roboz J; Hoffman R
Exp Hematol; 2015 Feb; 43(2):100-9.e1. PubMed ID: 25461253
[TBL] [Abstract][Full Text] [Related]
16. Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.
Tefferi A; Dingli D; Li CY; Dewald GW
Cancer; 2005 Oct; 104(8):1656-60. PubMed ID: 16104040
[TBL] [Abstract][Full Text] [Related]
17. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.
Tefferi A; Mesa RA; Nagorney DM; Schroeder G; Silverstein MN
Blood; 2000 Apr; 95(7):2226-33. PubMed ID: 10733489
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of extramedullary haematopoiesis in rabbits with saponin-induced myelofibrosis and myeloid metaplasia.
Wang JC; Tobin MS
Br J Haematol; 1982 Jun; 51(2):277-84. PubMed ID: 7082586
[TBL] [Abstract][Full Text] [Related]
19. Clonal analysis of agnogenic myeloid metaplasia.
Kreipe H; Jaquet K; Felgner J; Parwaresch MR
Leuk Lymphoma; 1992 Dec; 8(6):459-64. PubMed ID: 1363649
[TBL] [Abstract][Full Text] [Related]
20. Clonal granulocytes and bone marrow cells in the cellular phase of agnogenic myeloid metaplasia.
Kreipe H; Jaquet K; Felgner J; Radzun HJ; Parwaresch MR
Blood; 1991 Oct; 78(7):1814-7. PubMed ID: 1680495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
